Your browser doesn't support javascript.
Breakthrough infection with SARS-CoV-2 delta variant in old-age homes in a Southern District of Kerala, India.
Chandran, Dhanusha; Sreekumar, Easwaran; Prajitha, Kannamkottapilly Chandrasekharan; Sharahudeen, Anisha; Raveendran, Chithra Latha.
  • Chandran D; Junior Resident, Department of Community Medicine, Government Medical College, Thiruvananthapuram, Kerala, India.
  • Sreekumar E; Director, Institute of Advanced Virology, Thiruvananthapuram, Kerala, India.
  • Prajitha KC; Senior Resident, Department of Community Medicine, Government Medical College, Thiruvananthapuram, Kerala, India.
  • Sharahudeen A; Junior Resident, Department of Community Medicine, Government Medical College, Thiruvananthapuram, Kerala, India.
  • Raveendran CL; Assistant Surgeon, Department of Health Services, Kerala, India.
Indian J Public Health ; 66(Supplement): S36-S40, 2022 Nov.
Article in English | MEDLINE | ID: covidwho-2144164
ABSTRACT

Background:

The incidence of breakthrough infection with the emergence of new variants of concern of SARS-CoV-2 is posing a threat, and it is pertinent to understand the role of vaccines in protecting the elderly and people with comorbidities.

Objective:

The present study was undertaken to understand the natural history of SARS-CoV-2 infection in a closed cohort of the elderly population in an old-age home who have received two doses of COVID-19 vaccination. The study has also undertaken genomic sequencing to identify SARS-CoV-2 variants of concern from an academic perspective. Materials and

Methods:

A prospective observational study was conducted from March to August 2021 among residents of 11 old-age homes in Kerala who were vaccinated with 2 doses of the COVID-19 vaccine, from 2 weeks following vaccination. Samples with a threshold cycle value of <25 were subjected to targeted sequencing of the spike protein receptor-binding domain coding region.

Results:

Among the 479 vaccinated individuals, 86 (17.95%) turned positive during the follow-up period. The mean duration of symptoms was 3-5 days, and no hospitalization was required. A phylogenetic analysis of the nucleotide sequences from the samples indicated B.1.617.2 lineage representing the Delta strain.

Conclusion:

The evidence supports maximizing the vaccine coverage among vulnerable groups to prevent hospitalization and death rate on the verge of the emergence of new variants of SARS-CoV-2.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines / Variants Limits: Aged / Humans / Infant, Newborn Country/Region as subject: Asia Language: English Journal: Indian J Public Health Year: 2022 Document Type: Article Affiliation country: Ijph.ijph_1084_22

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines / Variants Limits: Aged / Humans / Infant, Newborn Country/Region as subject: Asia Language: English Journal: Indian J Public Health Year: 2022 Document Type: Article Affiliation country: Ijph.ijph_1084_22